Integrated Transcriptomics and Proteomics Identified CMPK1 as a Potential Biomarker for Type 2 Diabetes Mellitus.

Kang ZhaoRui MaoWei YiZhengyun Ren Yanjun LiuHuawu YangSenlin WangZhonghui Feng

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2024)

Our study showed CMPK1 was upregulated in the liver of T2DM patients and provides a possible new target for screening and diagnosing T2DM in patients with obese and a novel theoretical basis for the pathophysiological mechanism of obesity-related metabolic diseases.

Keyphrases

end stage renal disease
metabolic syndrome
weight loss
type diabetes
ejection fraction
glycemic control
newly diagnosed
chronic kidney disease
insulin resistance
mass spectrometry
peritoneal dialysis
prognostic factors
single cell
bariatric surgery
body mass index
weight gain
physical activity